Before prescribing, administering, or furnishing a prescription medication for an off-label use, a prescriber shall make every reasonable effort to:
(1) Explain to the patient, in easily understood terms, that the medication is not within the uses approved for that medication by the FDA; and
(2) Provide the patient with information regarding the potential risks and side effects associated with using the medication for the off-label use.
(Mar. 26, 2008, D.C. Law 17-131, § 203, 55 DCR 1659.)
This section is referenced in § 48-844.03.